XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Mar. 31, 2022
Equity [Abstract]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the nine months ended March 31, 2022 is reflected below:

  

   Number of Warrants   Weighted Average Exercise Price Per Warrant   Weighted Average Remaining Contract Term (# years) 
Warrants outstanding and exercisable at June 30, 2021   214,883   $4.49      
Warrants issued   1,071,430   $7.00      
Warrants outstanding and exercisable at March 31, 2022   1,286,313   $6.58    4.11 

 

Warrant detail for the nine months ended March 31, 2021 is reflected below:

 

   Number of Warrants   Weighted Average Exercise Price Per Warrant  

Weighted Average

Remaining Contract Term (# years)

 
Warrants outstanding and exercisable at June 30, 2020   83,205   $4.00      
Warrants issued   185,955   $4.80      
Warrants exercised   (32,977)  $4.80      
Warrants forfeited   (11,700)  $4.80      
Warrants outstanding at March 31, 2021   224,483   $4.50    3.22 
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in the Company’s stock options during the nine months ended March 31, 2022 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021   531,205   $11.02      
Granted   -   $-      
Exercised   (3,400)  $4.65      
Forfeited and cancelled   (15,612)  $14.28      
Outstanding and exercisable at March 31, 2022   512,193   $10.97    5.91 

 

Activity in the Company’s stock options during the nine months ended March 31, 2021 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020   579,584   $11.00      
Granted   -   $-      
Exercised   (15,812)  $5.77      
Forfeited and cancelled   (18,932)  $12.45      
Outstanding at March 31, 2021   544,840   $11.10    6.81 
Exercisable at March 31, 2021   490,493   $10.91    6.67 
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the nine months ended March 31, 2022 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Grant date Fair Value  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2021   131,652   $9.25      
Granted   179,614   $5.75      
Settled   (4.578)  $11.56      
Forfeited and cancelled   (35,542)  $6.95      
Outstanding at March 31, 2022   271,146   $7.19    2.34 

 

 

Activity in RSUs during the nine months ended March 31, 2021 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Grant date Fair Value  

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020   -   $-      
Granted   134,865   $8.88      
Forfeited and cancelled   (6,542)  $8.88      
Outstanding at March 31, 2021   128,323   $8.88    2.91 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants:

 

   2022   2021   2022   2021 
   Three Months Ended
March 31,
   Nine Months Ended
March 31,
 
   2022   2021   2022   2021 
Research and development  $32,000   $48,000   $122,000   $146,000 
Selling and administrative   120,000    180,000    479,000    504,000 
Total stock-based compensation expense  $152,000   $228,000   $601,000   $650,000